Background-Although obesity is associated with increased inflammation, it is unclear whether this accounts for the increased cardiovascular risk in obesity. This population-based study explored whether inflammation-sensitive plasma proteins (ISPs) modify the cardiovascular risk in overweight or obese men. Methods and Results-The ISPs (fibrinogen, orosomucoid, ␣1-antitrypsin, haptoglobin, ceruloplasmin) were measured in 6075 healthy men, aged 28 to 61 years. The incidences of cardiovascular events (myocardial infarction, stroke, cardiovascular deaths), cardiac events (fatal or nonfatal myocardial infarction), and stroke were followed-up over 18Ϯ4 years. High ISPs were associated with an increased cardiovascular risk in all categories of body mass index (BMI). The age-adjusted relative risks for cardiovascular events in obese men (BMI Ͼ30) were 2.1 (95% CI, 1.4 to 3.4), 2.4 (CI, 1.5 to 3.7), 3.7 (CI, 2.3 to 6.0), and 4.5 (CI, 3.0 to 6.6), respectively, for those with 0, 1, 2, and Ն3 ISPs in the top quartile (trend Pϭ0.002) (reference: BMI Ͻ25 and no elevated ISP). This trend persisted after adjustments for several potential confounders (Pϭ0.02). Incidence of cardiac events showed similar relations with the number of elevated ISPs in obese men.
S everal cohort studies have shown associations between obesity and an increased incidence of cardiovascular diseases. [1] [2] [3] [4] However, the risk could be very different for individuals with the same body mass. Two recent studies 2, 3 showed that the cardiovascular risk among obese subjects varies substantially depending on the levels of other risk factors associated with obesity. During the past years, elevated levels of inflammation-sensitive plasma proteins (ISPs) and other inflammatory markers have emerged as important cardiovascular risk factors, [5] [6] [7] [8] [9] [10] and it has been shown that inflammation adds important clinical information to traditional risk factors. 6, 7 To what extent a low-grade inflammation accounts for the increased risk of myocardial infarction and stroke in overweight and obese men is, however, largely unknown.
Cross-sectional studies have reported associations between obesity and different inflammatory markers. [11] [12] [13] It has been shown that the adipose tissue is an organ with endocrine functions, 14, 15 and it has been proposed that proinflammatory cytokines formed in the adipose tissue increase the hepatic synthesis of ISPs. 16 However, the relation between inflam-mation and body mass has not been fully explored. Obesity is associated with other risk factors, eg, hypertension, dyslipidemia, and diabetes, which could increase the obesityassociated inflammation. Whether body mass is similarly associated with inflammation in men without other risk factors has not been extensively studied.
Haptoglobin, fibrinogen, orosomucoid (␣1-acid glucoprotein), ␣1-antitrypsin, and ceruloplasmin are 5 ISPs that are used in clinical practice to measure the degree of inflammation and to differentiate between inflammatory diseases. It has been shown that human endothelial cells produce orosomucoid. 17 The hepatic synthesis of these proteins is, however, the main source and the production is chiefly regulated by various proinflammatory cytokines. 18, 19 Several studies from the population-based cohort Malmö Preventive Study have shown that these proteins are associated with an increased incidence of cardiac events and stroke. 5,6,20 -22 In 2 longitudinal studies, it was shown that elevated levels of these proteins predict a large weight gain 23 and the development of a high blood pressure. 24 This study explored the relationship between body mass index (BMI) and the ISPs, and whether these proteins modify the cardiovascular risk in obese and overweight men.
Methods
Between 1974 and 1984, 22 444 men participated in a screening program for detection of individuals at high risk for cardiovascular diseases. 25 Complete birth cohorts from the city of Malmö were invited. Participation rate was 71%. Determination of 5 plasma proteins was part of the program for 6193 men. These men were randomly selected from birth cohorts examined between 1974 and 1982. After exclusion of men with a history of myocardial infarction, stroke, or cancer (according to questionnaire), 6075 men remained. Mean age was 46.8Ϯ3.7 years (range, 28 to 61). The health service authority of Malmö approved and funded the screening program. All participants gave informed consent.
Baseline Examinations
Subjects were categorized as smokers and nonsmokers. The smokers were categorized as consumers of Յ9 cigarettes per day, 10 to 19 cigarettes per day, and daily consumption of Ն20 cigarettes. BMI was calculated as weight/height 2 (kg/m 2 ).
Blood pressure (mm Hg) was measured twice in the right arm after a 10-minute rest. The average of 2 measurements was used. A sphygmomanometer and a rubber cuff of appropriate size were used. Use of antihypertensive medication was assessed in a questionnaire.
Physical inactivity in spare time was assessed using the question, "Are you mostly engaged in sedentary activities in spare time, for example, watching TV, reading, going to the movies?" Subjects who confirmed a doctor's diagnosis of angina pectoris or who used nitrates were considered to have angina pectoris.
Blood samples were taken after an overnight fast. Serum cholesterol was analyzed with standard methods at the laboratory of the university hospital. Men with fasting whole blood glucose Ն6.1 mmol/L, men with 2-hour glucose values Ն10.0 mmol/L (glucose load, 30g/m 2 body surface area) 20, 26 and men who reported treatment for diabetes were considered diabetic patients. Serum levels of ␥-glutamyltransferase (␥-GT) were analyzed with standard methods at the hospital laboratory. 27 The ␥-GT values were log transformed because of the skewed distribution.
High alcohol consumption was assessed by means of the modified shortened version of the Michigan Alcoholism Screening Test. 27 Men with Ͼ2 (of 9) affirmative answers were considered to have high alcohol consumption.
Low Levels of Traditional Risk Factors
The relation between BMI and ISPs was specifically studied in men with low levels of traditional risk factors. This group was defined as nondiabetic nonsmokers without hypertension (Ն140/90 or treatment), dyslipidemia (cholesterol Ն6.5 mmol/L or triglycerides Ն2.3 mmol/L), and angina. 22
ISPs
Electroimmunoassay was used to assess the plasma levels of 5 ISPs. 28 The analysis was performed consecutively at the time of study entry. The detection limits were 20 mg/L for ceruloplasmin, 50 mg/L for ␣1-antitrypsin, and 350 mg/L for orosomucoid, haptoglobin, and fibrinogen. The precision of the analysis had a variation Ͻ5%. 28 We have previously shown that the correlation coefficients between the individual proteins range from 0.31 to 0.56. 5 We have also reported that all 5 ISPs are associated with cardiovascular disease and that the cardiovascular risk increases with the number of ISPs in the top quartile. 6, 21 The sample was categorized according to the number of ISPs in the top quartile. Two to 5 ISPs in the top quartile were denoted "high ISPs" and 0 to 1 ISP in the top quartile were "low ISPs." 6, 21 The top quartiles were as follows: fibrinogen Ͼ4.0 g/L, orosomucoid Ͼ0.93 g/L, ␣1-antitrypsin Ͼ1.42 g/L, haptoglobin Ͼ1.76 g/L, and ceruloplasmin Ͼ0.36 g/L.
Follow-Up
All men were followed-up from the baseline examination until death or December 31, 1997 (mean follow-up, 18.7Ϯ4.2 years). A cardiac event was defined as nonfatal myocardial infarction (code 410 according to the International Classification of Diseases, ICD, 9 th revision) or death caused by ischemic heart disease (ie, ICD codes 410 to 414). Stroke (fatal or nonfatal) was defined as cases coded 430 (subarachnoid hemorrhage), 431 (intracerebral hemorrhage), 434 (ischemic stroke), or 436 (unspecified) according the ICD. A cardiovascular event was defined as nonfatal stroke, nonfatal myocardial infarction, or death from cardiovascular disease (ICD-9 codes 390 to 448).
The Swedish Hospital Discharge Register, the Stroke register of Malmö, and the Swedish Cause of Death register were used for case retrieval. 6,29 -31 Of the 613 cardiac events, 209 were fatal within 28 days. Of the 209 fatal events, cause of death was based on autopsy in 146 (70%), on examination in hospital before death in 50 cases, examination outside hospital before death in 6 cases, and on other sources in 7 cases. A validation study from the Swedish Hospital Discharge Register showed that the diagnosis myocardial infarction was false in only 5% of the cases. 31
Statistics
Analysis of variance was used to study the relationships between BMI and ISP levels. A general linear model was used to adjust the relations for confounders and to test the linear effects across the quartiles of BMI. Cox proportional hazards model was used for the analysis of the event rates in categories of BMI and ISP with adjustment for potential confounders.
Results

ISPs in Relation to BMI
The baseline characteristics of the cohort are presented in Table 1 . The ISP levels in relation to quartiles of BMI in all men are presented in the first part of Table 2 . After adjustments for smoking and other confounders, fibrinogen, haptoglobin, and orosomucoid were positively and linearly associated with BMI. ␣1-Antitrypsin was highest in men with low BMI. Ceruloplasmin was unrelated to BMI.
With the purpose of further exploring whether the relations between ISPs and BMI were independent of other risk factors, men with low levels of the traditional risk factors were analyzed ( Table 2 ). As expected, the mean ISP concentrations were lower in this group. Fibrinogen, haptoglobin, and orosomucoid were still positively associated with BMI. ␣1-Antitrypsin and ceruloplasmin were unrelated to BMI in this subgroup. 
ISPs and BMI in Relation to Incidence of Cardiovascular Diseases
The men were categorized by quartile of BMI and number of ISPs in the top quartile (0 to 1 or 2 to 5). Among men in the fourth quartile of BMI, all 3 cardiovascular end points were significantly related to the ISPs. In all quartiles of BMI, the relative risks of cardiac events were significantly higher in those with elevated ISPs as compared with those with low ISPs. High BMI (quartile 4) was significantly associated with increased cardiovascular and cardiac events rates, even in men with low ISPs (Table 3 ).
Obese Men
A total of 437 men were obese (BMI Ͼ30). The proportion with 2 to 5 elevated ISPs was 41.6% in obese men, as compared with 33.6% in men with BMI Ͻ25. The obese group was categorized into men with 0, 1, 2, and Ն3 ISPs in the top quartile. The number of cardiovascular events were 23 (16.8%), 22 (18.6%), 20 (27.4%), and 34 (31.2%), respectively, for obese men with 0, 1, 2, and Ն3 ISPs in the top quartile (P for trendϭ0.003). The numbers of cardiac events were 15 (10.9%), 15 (12.7%), 14 (19.2%), and 26 (23.9%), respectively (P for trendϭ0.003). The numbers of stroke were 6 (4.4%), 7 (5.9%), 8 (11%), and 6 (5.5%), respectively (not significant).
The age-adjusted relative risks for cardiovascular events were 2.1 (95% CI, 1.4 to 3.4), 2.4 (CI, 1.5 to 3.7), 3.7 (CI, 2.3 to 6.0), and 4.5 (CI, 3.0 to 6.6), respectively, for obese men with 0, 1, 2, and 3 ISPs in the top quartile (trend Pϭ0.002) (reference, BMI Ͻ25 and no elevated ISP). This relation remained significant after full adjustments for potential confounders (Pϭ0.02) (Figure) . The multivariate-adjusted incidence of cardiac events in obese men showed similar relations with the number of elevated ISPs (P for trendϭ0.04).
Discussion
Many studies have reported an increased incidence of cardiovascular diseases in obese subjects. [1] [2] [3] [4] To what extent this could be related to a low-grade inflammation has been unclear. The present results show that obesity or overweight is associated with elevated levels of several ISPs. Moreover, the increased incidence of cardiovascular diseases among overweight or obese men was further elevated in those who also had elevated ISPs. It is concluded that relationships with elevated ISPs contribute to, but cannot fully explain, the increased cardiovascular risk in obese or overweight men. The results suggest that measurements of ISPs may be useful in a global risk assessment of obese men to identify those who urgently need risk factor intervention and weight reduction.
Cross-sectional studies have shown correlations between various inflammatory markers and measures of body fat. [11] [12] [13] Weight loss has been associated with reduced inflammation. 32 There could be several causes for this association. Proinflammatory cytokines formed in the adipose tissue, eg, IL-6 and tumor necrosis factor-␣, could increase the hepatic synthesis of ISPs. 14 -16 Obesity has been associated with oxidative stress, which could increase inflammation. 33 Other risk factors associated with obesity, eg, hyperglycemia, insulin resistance, dyslipidemia, diet, and hypertension, could also increase inflammation. 6, 20, 21, 34, 35 In accordance with a recent case-control study of obese women, 36 this study showed a relation between BMI and inflammation, even in men with low levels of other major risk factors. However, the reasons for the increased ISPs are unclear, and obesity per se is probably not the only explanation for an increased inflammation in obese men. It has even been shown that elevated ISPs predict a large weight gain and, thus, that a low-grade inflammation often occurs before the increased weight. 23 The reasons for the increased cardiovascular risk in obese men with high ISP levels are also incompletely understood. 10 Inflammation has been implicated in the pathogenesis of atherosclerosis and unstable atherosclerotic plaque in the coronary arteries. 8, 9 Obesity and high ISPs have been associated with persistent platelet activation, 36 which hypothetically could increase the incidence of cardiovascular diseases. It is also possible that the relation between inflammation and incidence of cardiovascular diseases partially is mediated through an increased incidence of other risk factors during follow-up, eg, hypertension, diabetes, and dyslipidemia. It has been shown that elevated ISPs are associated with an increased incidence of hypertension and diabetes. 24, 37 Three of the ISPs showed linear associations with BMI, both in all men and in men with low levels of the traditional risk factors. This is in accordance with a previous study on BMI and C-reactive protein. 12 However, the relationships were different for ceruloplasmin and ␣1-antitrypsin, and these proteins were unrelated to BMI in men with low risk factor levels. Although most inflammatory conditions are associated with elevated levels of all the ISPs in this study, it can be concluded that the relations with BMI are different for the inflammatory markers. It is noteworthy, however, that the relations with mortality and cardiovascular disease are similar for all 5 ISPs. 6 Whether the relationships between BMI and cardiovascular diseases should be adjusted for hypertension, diabetes, dyslipidemia, physical activity, or alcohol consumption, ie, determinants or physiological effects of obesity, is debatable. 38 It is likely that the risk factor-adjusted relative risks in Table 3 Men with diabetes, hypertension, and hypercholesterolemia were referred for further evaluation and treatment.
Smokers were recommended to stop but were not offered any help to do so. Because these factors were more common among men with high ISPs, it is likely that this group gained most from the interventions. Another limitation is that we do not know whether the subfractions of cholesterol differed between the groups with high and low ISPs. However, the ratio of low-density lipoprotein to high-density lipoprotein is correlated to levels of triglycerides, and the results were adjusted for triglyceride levels as a proxy for dyslipidemia.
The BMI was used to assess degree of overweight. We had no information on the distribution of body fat. Previous Multivariate-adjusted relative risks (95% CI) for cardiovascular events in men with 0, 1, 2, and Ն3 elevated ISPs by normal weight (BMI Ͻ25, nϭ3313) or obesity (BMI Ͼ30, nϭ437) (reference category, BMI Ͻ25, no elevated ISP). P for trends are PϽ0.0001 and Pϭ0.02, respectively, for normal weight and obese men. The covariates are listed in the Table 3 footnote. studies have shown that the relationships with measures of inflammation are largely similar for different measures of overweight 11, 13, 39 and that BMI or waist-to-hip ratio accounts for Ϸ10% to 15% of the variance in ISP levels. It is likely that the heterogeneity in ISP levels affects the prognosis similarly for men with obesity assessed by means of the waist circumference or waist-to-hip ratio.
Obesity is associated with elevated ISPs. The cardiovascular health hazard of overweight and obesity varies widely by the level of these proteins. Relationships with elevated ISPs contribute to, but cannot fully explain, the increased cardiovascular risk in obese men.
